Venous thromboembolism

Search with Google Search with Bing
Information
Disease name
Venous thromboembolism
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT04349189 Active, not recruiting Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell Trait September 1, 2020 October 15, 2026
NCT04168203 Active, not recruiting Phase 4 Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism March 1, 2021 June 30, 2025
NCT05498142 Active, not recruiting Predicting the Risk of Venous Thromboembolism in Critically Ill Patients March 2015 August 2023
NCT03870464 Active, not recruiting LIFE - Lung Cancer, Immunotherapy, Frailty, Effect April 1, 2018 April 1, 2028
NCT06218095 Active, not recruiting N/A Pregnancy and Postpartum Period Venous Thromboembolism and Simulation May 15, 2023 August 10, 2024
NCT05108389 Active, not recruiting Sonoclot to Evaluate Thrombotic Risk in Proteinuric Pregnancy March 1, 2022 October 1, 2023
NCT05819112 Active, not recruiting A Comparison of Extended Versus Conventional Duration of Enoxaparin Prophylaxis (i.e., Preventive Treatment) for Venous Thromboembolism (VTE, i.e., Blood Clots in the Veins) and Bleeding Event Risk in a Population With Acute Medical Illness April 25, 2023 April 2024
NCT03477968 Active, not recruiting ThRombosis ExclUsion STudy June 25, 2018 December 31, 2024
NCT03068923 Active, not recruiting Thrombosis Outcomes in Pediatric Venous Thromboembolism May 2016 December 2024
NCT05819125 Active, not recruiting Comparison of the Risk of Venous Thromboembolism (i.e., Blood Clots in the Veins) and Bleeding Events in a Population of Obese Patients Receiving Higher-Dose or Extended-Duration Versus Conventional-Dose or Conventional-Duration of Prophylaxis (i.e., Preventive Treatment) With Enoxaparin April 25, 2023 April 2024
NCT04737954 Active, not recruiting N/A A Performance Evaluation of the LumiraDx Point Of Care D-dimer Assay March 18, 2021 September 2022
NCT00182221 Completed Phase 3 Safety of a Diagnostic Strategy With D-Dimer Testing for PE August 2003 April 2008
NCT00182403 Completed Phase 3 Fixed Dose Heparin Study September 1998 May 2004
NCT00196118 Completed Phase 4 Study of IVC Filter Retrieval With the Günther Tulip Vena Cava Filter April 2005 July 2007
NCT00201903 Completed The Roles of Tissue Factor in Malignant Gliomas January 2004 October 2006
NCT00219973 Completed Phase 3 CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation) May 2005 April 2009
NCT00244725 Completed Phase 2 Odiparcil For The Prevention Of Venous Thromboembolism September 2005 September 2006
NCT00329628 Completed Phase 3 Rivaroxaban (10mg) Given Once Daily in Patients Undergoing Total Hip Replacement Compared to Enoxaparin February 2006 March 2007
NCT00331838 Completed Phase 2 Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery May 2006 June 2007
NCT00332020 Completed Phase 3 Regulation of Coagulation in Orthopedic Surgery to Prevent DVT and PE, a Controlled, Double-blind, Randomized Study of BAY 59-7939 in the Extended Prevention of VTE in Patients Undergoing Elective Total Hip Replacement February 2006 June 2007
NCT00333021 Completed Phase 3 Abdominal Surgery Study Of GSK576428 (Fondaparinux Sodium)In Japanese Patients May 2006 February 2007
NCT00338897 Completed Phase 2/Phase 3 Dose Ranging Study in Elective Total Hip Replacement Surgery May 2006 May 2007
NCT00361647 Completed N/A Screening for Occult Malignancy in Idiopathic Venous Thromboembolism January 2006
NCT00361894 Completed Phase 3 Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). A Study of BAY 59-7939 in the Prevention of VTE in Subjects Undergoing Elective Total Knee Replacement. February 2006 January 2007
NCT00362232 Completed Phase 3 Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thromboembolism (DVT) and Pulmonary Embolism (PE). A Study of BAY59-7939 in the Prevention of Venous Thrombo Embolism (VTE) in Subjects Undergoing Elective Total Knee Replacement. June 2006 January 2008
NCT00395772 Completed Phase 2 Once-daily Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Deep-vein Thrombosis December 2004 December 2005
NCT00396786 Completed Phase 2 Dose-ranging Study of Once-daily Regimen of BAY 59-7939 in the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement November 2004 July 2005
NCT00398905 Completed Phase 2 Dose-Ranging Study of BAY 59-7939 on the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement January 2004 September 2004
NCT00402467 Completed Phase 2 An Oral, Direct Factor Xa Inhibitor, BAY59-7939, for Prophylaxis Against Venous Thromboembolism After Total Knee Replacement: a Dose-Ranging Study February 2004 November 2004
NCT00439725 Completed Phase 3 Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension Study February 2007 September 2009
NCT00456196 Completed Epidemiology of Venous Thromboembolism April 2006 June 2009
NCT00470626 Completed N/A Celect Vena Cava Filter Clinical Trial November 2005 March 2009
NCT00476216 Completed Phase 1 Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung Cancer September 2007 December 2013
NCT00523614 Completed Use of Oral Contraceptives (OCs) Containing Dienogest and Risk of Venous Thromboembolism July 2007 June 2008
NCT00531843 Completed Phase 2/Phase 3 The Use of Fondaparinux in Preventing Thromboembolism in High Risk Trauma Patients December 2007 June 2008
NCT01203072 Completed Phase 2 A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty July 2006 July 2008
NCT00005351 Completed Incidence and Outcomes of Venous Thromboembolism August 1991 July 1994
NCT00005496 Completed Inflammation, Infection, and Future Cardiovascular Risk September 1998 August 2002
NCT00005515 Completed Mutations, Hormone Therapy (HRT) and Venous Thromboembolism September 1998 August 2003
NCT00005543 Completed Genetic Epidemiology of Venous Thromboembolism April 1999 June 2005
NCT00005684 Completed Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in Thrombosis March 1996 January 2001
NCT00007085 Completed N/A Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED II) September 2000 December 2004
NCT00063518 Completed Monitoring Trends in Venous Thromboembolism April 2003 December 2007
NCT00077753 Completed Phase 4 EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged Immobilization February 2002 February 2007
NCT00119457 Completed Phase 2 Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial) January 2005 April 2006
NCT00135876 Completed Phase 3 Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients October 2002 November 2006
NCT01362933 Completed National Evaluation of the Adherence to Recommendations of Venous Thrombo Embolism Treatment in Cancer Patients May 2011 July 2012
NCT01401725 Completed N/A Electronic Strategies to Enhance Venous Thromboemboli (VTE) Prophylaxis in Hospitalized Medical Patients April 2011 June 2012
NCT01403090 Completed Phase 1 Safety Study of the Angel™ Catheter in Subjects With Risk of Pulmonary Embolism December 2011 March 2012
NCT01431456 Completed Phase 3 Safety of DAbigatran and RIvaroxaban Versus NAdroparin in the Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery September 2013 October 2014
NCT01467583 Completed Phase 4 Fondaparinux in Critically Ill Patients With Renal Failure November 2011 November 2013
NCT01524393 Completed Risk of Pulmonary and Venous Thromboembolism in Pregnancies After in Vitro Fertilization January 1990 December 2010
NCT01524653 Completed Phase 2 Detecting the Impact of Statin Therapy On Lowering Risk of Venous Thrombo-Embolic Events (DISOLVE) March 2012 September 1, 2016
NCT01559207 Completed Reproducibility of Plasma Nucleosomes and Free DNA as Markers for Venous Thromboembolism April 2013 October 2014
NCT01561885 Completed N/A Collaborative Healthcare Professionals Approach in Monitoring of Patient Centered Outcomes Through Pathways March 2012 March 2016
NCT01598805 Completed N/A Increased Rate of Prophylaxis Against Venous Thromboembolism Due to eAlerts June 2012 September 2012
NCT01602445 Completed Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism July 2012 October 2016
NCT01629381 Completed Phase 2 Efficacy of RIvaroxaban for Prevention of Venous Thromboembolism After Knee Arthroscopy May 2012 March 2014
NCT01653405 Completed N/A Improving Anticoagulation Control in VISN 1 October 1, 2014 September 30, 2016
NCT01713361 Completed Phase 2 Active Comparator-Controlled Study to Assess Safety and Efficacy of ISIS-FXIRx in Total Knee Arthroplasty October 2012 August 2014
NCT01720108 Completed Phase 3 Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban to Aspirin Following Total Hip and Knee Arthroplasty February 24, 2013 July 2016
NCT01744431 Completed Can Thrombin Generation Measurement Predict the Risk of Venous Thromboembolism in Acute Ill Patients December 2012 September 2013
NCT01781858 Completed Study on the Clinical Course Of Pulmonary Embolism January 2008 July 2014
NCT01803022 Completed Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer November 2012 July 2013
NCT01809015 Completed Evaluation of Oral Anticoagulation With Vitamin K Antagonists - The thrombEVAL Study Programme January 2011 March 2018
NCT01835990 Completed Phase 2 Feasibility Study of Geko vs. IPCs in Trauma July 2013 August 2014
NCT01851239 Completed Venous Thromboembolism Prophylaxis in Medical and Surgical ICUs in a Single University Hospital February 2013 April 2014
NCT01857583 Completed Phase 3 Safety and Pharmacokinetics Study of DU-176b Administered to Patients With Severe Renal Impairment Undergoing Orthopedic Surgery of The Lower Limbs March 2012 December 2012
NCT01869075 Completed N/A Toronto Thromboprophylaxis Patient Safety Initiative July 2006 March 2009
NCT01885585 Completed Eliquis Regulatory Post Marketing Surveillance (rPMS) July 2014 May 2015
NCT01895777 Completed Phase 3 Open Label Study Comparing Efficacy and Safety of Dabigatran Etexilate to Standard of Care in Paediatric Patients With Venous Thromboembolism (VTE) September 25, 2013 November 14, 2019
NCT01958203 Completed Venous Thromboembolism Prophylaxis in a Tertiary UAE Hospital: Comparison of Clinical Practice Guidelines. January 2013 September 2013
NCT01972243 Completed Risk of Recurrent Venous Thrombosis: A Validation Study of the Vienna Prediction Model September 2013 May 2021
NCT01976988 Completed Phase 3 Prospective Study on Preoperative Versus Postoperative Venous Thromboprophylaxis in Patients Undergoing Major Colorectal Surgery September 2013 May 2015
NCT01984190 Completed Multicenter Registry for Effectiveness Analysis of ActiveCare+S.F.T® Mobile Compression Device for Thrombosis Prevention in Hip and Knee Arthroplasty April 2011 October 2011
NCT02048865 Completed Phase 2 Apixaban for the Prevention of Venous Thromboembolism in Cancer Patients March 24, 2014 October 19, 2018
NCT02064439 Completed Phase 3 Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism) March 5, 2014 November 4, 2016
NCT02070237 Completed Phase 1 Comparing Anti-XA Levels in Post-Cesarean Patients Undergoing Enoxaparin Thromboprophylaxis August 2013 March 2014
NCT02079584 Completed Outpatient Treatment of Low-Risk Venous Thromboembolism With Target Specific Anticoagulant March 2013 August 14, 2014
NCT02095509 Completed Phase 4 Pharmacokinetics of Enoxaparin in Intensive Care Patients March 2014 September 30, 2016
NCT02155491 Completed Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events July 7, 2014 September 30, 2020
NCT02170701 Completed Phase 2 BIBR 1048 in the Prevention of Venous Thromboembolism in Patients Undergoing Primary Elective Total Hip Replacement Surgery October 2000
NCT02170935 Completed Phase 2 Pharmacokinetic (PK) Assessment of BIBR 1048 in Patients After Primary Elective Total Hip Replacement Surgery April 2002
NCT02185027 Completed Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants June 2013 December 2016
NCT02186223 Completed N/A The Angel® Catheter Pivotal Clinical Trial January 2015 December 2015
NCT02197416 Completed Phase 3 Safety of Dabigatran Etexilate in Blood Clot Prevention in Children September 29, 2014 November 19, 2019
NCT02213978 Completed A Clinical Cohort Study of Safety and Effectiveness of Venous Thromboembolism Prophylaxis in Critical Ill Patients August 2014 December 2021
NCT02223260 Completed Phase 2 Tolerability , PK/PD and Safety of Dabigatran Etexilate Oral Liquid Formulation in Children < 1 Year of Age September 2014 February 2016
NCT02234843 Completed Phase 3 EINSTEIN Junior: Oral Rivaroxaban in Children With Venous Thrombosis November 13, 2014 January 30, 2019
NCT02248610 Completed Follow-up in Rivaroxaban Patients in Setting of Thromboembolism November 2014 July 31, 2020
NCT02271399 Completed Phase 2 Comparative Study of Prophylactic Agent for Venous Thromboembolism After Total Knee Arthroplasty October 2014 February 2016
NCT02297373 Completed Clinical Predictors for Venous Thromboembolism in Patients With a History of Thrombosis (PREDICTORS) November 19, 2014 January 3, 2019
NCT02301793 Completed N/A Educating Nurses About Venous Thromboembolism (VTE) Prevention April 1, 2014 March 31, 2015
NCT02303431 Completed Phase 1 Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) Study November 5, 2014 September 16, 2021
NCT02309411 Completed Phase 2 EINSTEIN Junior Phase II: Oral Rivaroxaban in Young Children With Venous Thrombosis January 15, 2015 April 5, 2017
NCT02334007 Completed Phase 1/Phase 2 Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery September 2015 September 2018
NCT02366871 Completed Phase 2 Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy April 28, 2015 June 2019
NCT02379806 Completed Phase 3 The SYMPTOMS - SYstematic Elderly Medical Patients Thromboprophylaxis: Efficacy on Symptomatic OutcoMeS - Study September 3, 2015 December 29, 2020
NCT02402881 Completed N/A Education Bundle to Decrease Patient Refusal of VTE Prophylaxis April 2015 November 2018
NCT02411292 Completed Phase 2 Enoxaparin Metabolism in Reconstructive Surgery Patients March 2015 June 2016
NCT02412982 Completed Phase 4 Evaluation of Venous Thromboembolism Prevention in High-Risk Trauma Patients March 2016 January 2019
NCT02443610 Completed Haemorrhages and Thromboembolic Venous Disease of the Postpartum January 6, 2015 April 27, 2021
NCT02464969 Completed Phase 4 Apixaban for the Acute Treatment of Venous Thromboembolism in Children November 22, 2015 April 30, 2024
NCT02474212 Completed Phase 4 : Pharmacokinetics of Enoxaparin After Coronary Artery Bypass Graft Surgery May 2016 March 31, 2023
NCT02546817 Completed Eliquis (VTE Treatment and Prevention of Recurrent VTE) rPMS November 30, 2015 September 29, 2017
NCT02558465 Completed Special Drug Use Investigation of Xarelto for Venous Thromboembolism (VTE) November 13, 2015 May 31, 2021
NCT02559856 Completed Phase 4 Comparison of Bleeding Risk Between Rivaroxaban and Apixaban May 2016 February 2018
NCT02585713 Completed Phase 3 Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism November 20, 2015 December 24, 2019
NCT02596230 Completed RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism November 5, 2015 March 31, 2019
NCT02661568 Completed Description of Patients With Acute Venous Thromboembolism in the UK's Clinical Practice Research Datalink Linked With Hospital Episode Statistics Dataset (CPRD-HES) September 2014 December 2015
NCT02687204 Completed Phase 1 Twice Daily Enoxaparin Prophylaxis in Reconstructive Surgery Patients March 2016 December 6, 2017
NCT02704052 Completed Early Phase 1 Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Dose March 2016 October 2018
NCT02713581 Completed IgG Dependent Monocyte Activation in Proximal Venous Thromboembolism January 3, 2017 June 23, 2020
NCT02739867 Completed Tumor-educated Platelets in Venous Thromboembolism June 2016 October 2021
NCT02744092 Completed N/A Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer December 13, 2016 February 22, 2021
NCT02746185 Completed Phase 3 Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban September 2016 April 25, 2018
NCT02774265 Completed Phase 3 A Different Approach to Preventing Thrombosis January 2016 September 2017
NCT02795065 Completed N/A Bemiparin Versus Enoxaparin in the Prevention of Venous Thromboembolism Among ICU Patients March 2014 March 2016
NCT02828904 Completed RIVET - Retrospective Cohort Study on the Risk of Venous Thromboembolism March 10, 2022 January 31, 2024
NCT02829957 Completed Phase 2/Phase 3 RAMBLE - Rivaroxaban vs. Apixaban for Heavy Menstrual Bleeding September 2016 February 13, 2020
NCT02833987 Completed Direct Oral Anticoagulants and Venous Thromboembolism March 2015 March 2015
NCT02836457 Completed ELIQUIS (APIXABAN) Regulatory Post-Marketing Surveillance In Clinical Practice for Venous Thromboembolism (VTE) Treatment and Prevention Of Recurrent VTE July 1, 2016 July 31, 2018
NCT02856295 Completed Phase 4 anti10a Levels in Women Treated With LMWH in the Postpartum Period November 20, 2021 August 1, 2022
NCT02864537 Completed N/A Self-management of Anticoagulation Treatment January 2009 March 2013
NCT02870296 Completed N/A Anticoagulation Medical Home October 21, 2016 January 5, 2018
NCT02895971 Completed Incidence of Venous Thromboembolism and Professional Practices in Brest Area March 4, 2013 June 30, 2017
NCT02898090 Completed Development and Validation of Automated Indicators on the Appropriateness of Oral Anticoagulant Prescriptions April 28, 2018 February 1, 2022
NCT02904967 Completed N/A Identification of New Genetic Markers of Risk of Venous Thromboembolism Recurrence by Analyzing Whole Genome January 18, 2013 August 9, 2023
NCT02912234 Completed Phase 1 Effect of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Participants September 2016 October 2016
NCT02935530 Completed Phase 3 Thromboprophylaxis After Surgery for Gynecologic Malignancy in China January 2016 October 2017
NCT02943993 Completed Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Europe April 6, 2016 December 1, 2020
NCT02950168 Completed Edoxaban Management in Diagnostic and Therapeutic Procedures November 2016 July 26, 2018
NCT02952599 Completed Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Korea and Taiwan (ETNA-VTE-KOR-TWN) March 27, 2017 October 29, 2019
NCT02958969 Completed Phase 4 Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma February 28, 2018 November 19, 2019
NCT02969343 Completed N/A Patient Safety Learning Laboratory: Making Acute Care More Patient-Centered April 2015 December 2018
NCT02970032 Completed Early Phase 1 Evaluation of Anti-Xa Levels in Surgery Patients Receiving Fixed Dose Heparin November 10, 2016 December 8, 2017
NCT03025100 Completed VTE Prophylaxis Guidelines in Hospitalized Elders February 2016 March 4, 2017
NCT03031457 Completed Microsurgical Breast Reconstruction & VTE January 30, 2017 December 15, 2017
NCT03044574 Completed N/A Intermittent Pneumatic Compression in Surgical Patients at Extremely-high Risk for Venous Thromboembolism February 1, 2017 December 31, 2018
NCT03054727 Completed Long Term Assessment of Post Thrombotic Syndrome : OPTIMEV Study ( SPOT ) July 11, 2017 December 31, 2022
NCT03070834 Completed N/A RIPT Feasibility Trial July 1, 2017 February 28, 2020
NCT03083782 Completed Phase 1 Drug Interaction Study of Apixaban With Cyclosporine and Tacrolimus April 18, 2017 June 30, 2017
NCT03087474 Completed Treatment of Venous Thromboembolism in Real-Life Patients December 4, 2015 June 28, 2018
NCT03099031 Completed Non Interventional Study of the Validation of the Ottawa Score in Cancer Patients With Venous Thromboembolism (VTE) May 2015 May 15, 2017
NCT03115541 Completed Incidence of Venous Thromboembolism in Patients Undergoing Major Esophageal Resection July 10, 2017 September 1, 2020
NCT03124017 Completed N/A Electronic Alert System for Improving Thromboprophylaxis in Hospitalized Medical Patients March 2015 June 2016
NCT03134820 Completed Time of Treatment With LMWH in Cancer Patients With Thromboembolic Disease December 15, 2015 March 31, 2017
NCT03141749 Completed Venous Thromboembolism in DM1 January 2000 January 2017
NCT03158792 Completed Phase 4 Enoxaparin 20mg Versus 30mg Subcutaneously Once Daily in Elderly Patients With Impaired Renal Function October 24, 2015 July 13, 2017
NCT03212365 Completed Phase 2 Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive Surgery July 3, 2017 October 1, 2019
NCT03214172 Completed Characterizing Recurrent Thromboembolism, Major Bleeding and All-Cause Death in Patients With Cancer-Associated Thromboembolism Treated With Rivaroxaban July 15, 2017 September 15, 2017
NCT03243708 Completed N/A Title: Randomized Trial of an EHR Embedded Risk Calculator vs. Standard VTE Prophylaxis for Medical Patients December 4, 2017 April 14, 2019
NCT03251963 Completed Phase 2 Fixed Versus Weight-Based Enoxaparin Dosing in Thoracic Surgery Patients September 15, 2017 July 27, 2019
NCT03282747 Completed Distribution of Risk Factors for Venous Thromboembolism in Blood Donors July 15, 2017 December 30, 2018
NCT03285438 Completed Phase 3 REduced Dose Versus Full-dose of Direct Oral Anticoagulant After uNprOvoked Venous thromboEmbolism. November 2, 2017 November 8, 2023
NCT03292666 Completed Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism Study January 1, 2010 June 21, 2022
NCT03339349 Completed Phase 2 Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic Trauma November 15, 2017 October 29, 2019
NCT03381963 Completed Hemostatic Profiles of Endocrine Therapies for Breast Cancer April 1, 2017 February 28, 2020
NCT03404635 Completed Monotherapy Anticoagulation To Expedite Home Treatment of Venous Thromboembolism August 4, 2017 May 8, 2020
NCT03475771 Completed Retrospective Evaluation of Thrombo-embolic Complication in Pelvic Fracture Surgery March 24, 2017 January 4, 2018
NCT03516656 Completed Early Phase 1 Evaluation of Anti-Xa Levels in Surgery Patients Receiving Weight-based Heparin March 23, 2018 August 24, 2021
NCT03535090 Completed Coagulation After Intravenous Methylprednisolone Administration January 1, 2011 December 31, 2014
NCT03535428 Completed Venous Thrombo-embolic Complication prévention in Pelvic Surgery February 13, 2017 August 31, 2019
NCT03646409 Completed Venous Thromboembolism and Bleeding Risk in Patients With Esophageal Cancer June 11, 2018 December 1, 2018
NCT03660007 Completed Incidence of Pulmonary and Venous Thromboembolism in IVF Pregnancies After Fresh and Frozen Embryo Transfer January 1, 1992 December 31, 2014
NCT03799016 Completed An Observational Study on Incidence, Natural History and Treatment Patterns of Venous Thromboembolism in Taiwan December 15, 2016 July 1, 2017
NCT03812328 Completed Phase 2 Study to Assess the Safety and Efficacy of SelK2 to Prevent Blood Clots in Patients Undergoing Total Knee Replacement February 20, 2019 November 14, 2019
NCT03835780 Completed The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort Study February 1, 2019 December 1, 2019
NCT03919890 Completed Phase 1 A Two-Part Study to Assess the Safety, Tolerability, PK and PD of ONO-7684 in Healthy Adult Volunteers January 17, 2019 August 23, 2019
NCT03949985 Completed Longitudinal Hemostatic Profile After Stopping Estroprogestative Contraceptives October 8, 2018 September 14, 2020
NCT04041843 Completed Phase 2 Oral Anticoagulant Apixaban for Treatment of Venous Thromboembolism June 2, 2017 May 31, 2022
NCT04064489 Completed N/A Thromboembolic Risk Stratification by TRiP(Cast) Score to Guide Physicians in Preventive Treatment Prescriptions for Patients With Lower Limb Trauma Requiring Brace or castING. June 16, 2020 February 4, 2022
NCT04068727 Completed N/A LEAVE Safe With DOACs December 2, 2019 September 14, 2022
NCT04153760 Completed Early Phase 1 Pilot PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity October 7, 2020 September 5, 2023
NCT04157881 Completed Phase 4 A Study on the Impact of Rabeprazole-induced Elevated Stomach pH on APO-Dabigatran Exposure in Healthy Volunteers January 3, 2020 January 18, 2022
NCT04195113 Completed Perioperative Anticoagulant Use for Surgery Evaluation Emergency Registry August 7, 2019 December 31, 2022
NCT04257305 Completed Study of Venous Thromboembolism Risk Profiles and Prophylaxis in Neurosurgical Inpatients June 1, 2018 December 31, 2019
NCT04272723 Completed Management of Venous Thromboembolism in France: a National Survey Among Vascular Medicine Physicians August 21, 2019 July 1, 2023
NCT04352439 Completed Phase 4 Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy August 8, 2020 March 2, 2022
NCT04374617 Completed Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19 April 1, 2020 May 1, 2020
NCT04393909 Completed N/A Improving Safety of Diagnosis and Therapy in the Inpatient Setting July 1, 2019 December 30, 2021
NCT04400877 Completed Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 Pandemic June 8, 2020 September 30, 2020
NCT04409834 Completed Phase 4 Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial August 5, 2020 March 10, 2022
NCT04439383 Completed Risk Stratification for Venous Thromboembolism in Hospitalized Medical Patients June 22, 2020 April 1, 2022
NCT04444804 Completed Study to Compare the Effectiveness of Rivaroxaban (Xarelto) Versus Low-molecular-weight Heparin (LMWH) and Phenprocoumon for the Treatment and Secondary Prevention of Venous Thromboembolism in Routine Clinical Practice in Germany July 31, 2020 April 30, 2021
NCT04477564 Completed Clonal Hematopoiesis of Indeterminate Potential in Venous Thromboembolism July 3, 2020 December 30, 2022
NCT04479579 Completed Phase 4 Improved Adherence With Extended Venous Thromboembolism Prophylaxis After Major Cancer Surgery February 22, 2021 November 6, 2021
NCT04569344 Completed COVID-19 and Venous Thromboembolism Risk January 1, 2020 June 21, 2022
NCT04574895 Completed N/A Using a Real-Time Risk Prediction Model to Predict Pediatric Venous Thromboembolism (VTE) Events November 2, 2020 December 1, 2023
NCT04625673 Completed N/A OsciPulse Device for the Prevention of VTE May 12, 2021 October 15, 2022
NCT04646993 Completed WHITE Study: WHIch Decision After a First Venous ThromboEmbolism? February 1, 2018 February 28, 2022
NCT04662684 Completed Phase 3 Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy: The MICHELLE Trial October 16, 2020 August 30, 2021
NCT04735523 Completed Replication of the RECOVER-II Anticoagulant Trial in Healthcare Claims Data September 22, 2020 February 18, 2021
NCT04736420 Completed Replication of the EINSTEIN-DVT Anticoagulant Trial in Healthcare Claims Data September 22, 2020 February 18, 2021
NCT04736719 Completed Replication of the AMPLIFY Anticoagulant Trial in Healthcare Claims Data September 22, 2020 February 18, 2021
NCT04744688 Completed Changes in Coagulation in Colorectal Cancer Patients Undergoing Surgical Treatment April 6, 2021 May 27, 2024
NCT04768036 Completed N/A A Universal Electronic Health Record-based IMPROVE DD VTE Risk Assessment Model for the Prevention of Thromboembolism in Hospitalized Medically Ill Patients December 21, 2020 January 21, 2022
NCT04824118 Completed Clotting Parameters After Medical Abortion March 26, 2021 August 12, 2021
NCT04846556 Completed Cancer Associated Thrombosis : What is the Proportion of Patients Ineligible to a Study as CARAVAGGIO April 1, 2022 June 30, 2022
NCT04865913 Completed Venous Thrombosis Virtual Surveillance in COVID-19 January 13, 2021 December 31, 2022
NCT04920487 Completed Prevalence of Gynecological Pathologies and Use of Hormonal Treatments in Women Hospitalized for a Venous Thromboembolic Episode June 5, 2021 December 31, 2022
NCT04940377 Completed Effect of the Genotype on Postoperative DVT June 1, 2020 June 1, 2021
NCT04947514 Completed Phase 4 Use of Tranexamic Acid in Reduction Mammoplasty October 29, 2021 July 13, 2022
NCT04963374 Completed the Effectiveness of Different Risk Scales In Predicting VTE in Respiratory Inpatients April 1, 2021 December 31, 2022
NCT04969653 Completed The Incidence of Venous Thromboembolism in Atopic Dermatitis June 21, 2021 July 1, 2023
NCT05022563 Completed Treatment Patterns and Bleeding Risk of Anticoagulants in Patients With Venous Thromboembolism in Korea August 31, 2021 September 30, 2021
NCT05058521 Completed Venous thromboEmbolism Risk Profiles in Chinese hoSpitalized patiEnts (VERSE Study) June 1, 2018 April 30, 2020
NCT05143567 Completed N/A Hemostasis and Inflammation in COVID-19 Patients With Venous and Arterial Thrombotic Complications November 1, 2021 July 23, 2023
NCT05185804 Completed Phase 3 Clinical Trial of Dimolegin (DD217) in Prevention of Thrombotic Complications in Patients With COVID-19 February 8, 2021 October 29, 2021
NCT05195372 Completed Effectivity and Safety of Different Anticoagulants in Patients With Thromboembolic Antiphospholipid Syndrome January 1, 2015 July 2022
NCT05209048 Completed Risk Factors and a nOmogram of Venous thromboEmbolism in Patients After liveR Transplantation(ROVER Study) August 1, 2018 December 31, 2021
NCT05264168 Completed Prediction of the COBRRA VTE Anticoagulant Trial in Healthcare Claims Data May 3, 2021 June 15, 2022
NCT05439187 Completed Risk Factors of Venous Thromboembolism After Incisional Ventral Hernia Repair. January 1, 2018 January 31, 2020
NCT05461807 Completed An Observational Study Called H2H-OSCAR-US to Learn More About How Well Rivaroxaban Works and How Safe it is Compared to Apixaban Under Real World Conditions in People in the US With Cancer Who Have Problems Due to Formation of Blood Clots in the Veins (Venous Thromboembolism) July 14, 2022 October 5, 2022
NCT05487066 Completed Efficacy of ICU-VTE Scale in ICU Patients May 1, 2022 December 10, 2023
NCT05515120 Completed Phase 2/Phase 3 Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events January 3, 2021 July 1, 2022
NCT05541978 Completed Thrombosis in Patients With Multiple Myeloma in an University Medical Center September 1, 2022 March 1, 2023
NCT05618808 Completed Phase 2 A Trial to Learn How Well REGN9933 Works for Preventing Blood Clots After Knee Replacement Surgery in Adult Participants May 24, 2023 May 27, 2024
NCT05795062 Completed Treatment Patterns Among Patients With Venous Thromboembolism in the United States March 10, 2023 July 30, 2023
NCT05878899 Completed Phase 3 Postpartum Heparin Against Venous Thromboembolism: a Pilot Randomized Controlled Trial May 3, 2022 March 13, 2023
NCT05897697 Completed Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study September 24, 2021 October 7, 2022
NCT05926518 Completed Anti-Xa Level With Thromboprophylactic Dosage Nadroparin in Critically Ill COVID-19 and Non-COVID-19 Patients November 1, 2020 November 23, 2022
NCT06258694 Completed Venous Thrombo-Embolism Imaging Database (VTE-ID) January 14, 2021 February 15, 2021
NCT06302179 Completed Risk Factors of Venous Thromboembolism After Colorectal Cancer Surgery January 2015 May 2023
NCT06445283 Completed Determination of Venous Thromboembolism Risk and Nursing Practices in Patients Hospitalized in Medical Services February 21, 2024 February 21, 2024
NCT00558259 Completed Phase 3 Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE November 2007
NCT00571649 Completed Phase 3 Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients December 2007 November 2010
NCT00604370 Completed Retrospective Study to Review Patients at Risk for VTE at Hospital Discharge February 2008 December 2011
NCT00631423 Completed Evaluation of Patients With Vena Cava Inferior Thrombosis July 2007 August 2014
NCT00634907 Completed N/A Prospective Genotyping For Total Hip or Knee Replacement Patients Receiving Warfarin (Coumadin) September 2006 October 2008
NCT00641732 Completed Phase 2 Efficacy and Safety of TAK-442 in Subjects Undergoing Total Knee Replacement October 2007 October 2008
NCT00657150 Completed Phase 3 Dabigatran Etexilate Compared With Enoxaparin in Prevention of Venous Thromboembolism (VTE) Following Total Hip Arthroplasty March 2008
NCT00660205 Completed Venous Thromboembolism and Haemostatic Disturbances in Patients With Upper Gastrointestinal Cancer February 2008 February 2011
NCT00676065 Completed Long-term Active Surveillance Study for Oral Contraceptives (LASS) February 2001 December 2011
NCT00679588 Completed Phase 3 Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery April 2008 August 2010
NCT00683397 Completed Frankfurt Thrombophilia Registry May 2008 December 2014
NCT00689520 Completed Phase 4 Long-Term Low-Molecular-Weight Heparin Versus Oral Anticoagulants in Deep Venous Thrombosis January 2002 January 2005
NCT00694382 Completed Phase 3 Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy June 2008 November 2010
NCT00697099 Completed Phase 3 Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Total Hip Replacement Surgery June 2008 June 2009
NCT00709904 Completed Phase 3 Evaluation of AVE5026 as Compared to Placebo for the Extended Prophylaxis of Venous Thromboembolism in Patients Having Undergone Hip Fracture Surgery June 2008 January 2010
NCT00718224 Completed Phase 3 Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Elective Knee Replacement Surgery July 2008 May 2009
NCT00721760 Completed Phase 3 Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Hip Fracture Surgery July 2008 October 2009
NCT00755300 Completed Total Knee Arthroplasty And Thromboembolism: A Comparison Between Two Surgical Techniques June 2006 June 2009
NCT00773448 Completed N/A Screening for Occult Malignancy in Patients With Idiopathic Venous Thromboembolism September 2008 April 2015
NCT00774748 Completed N/A Once Weekly Subcutaneous Ports for the Administration of Anticoagulants August 2008 April 2010
NCT00788736 Completed Predicting Bleeding Risk on Anticoagulant Therapy for Venous Thromboembolism September 2008 October 2016
NCT00790335 Completed Phase 3 Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis November 2009 January 2017
NCT00810784 Completed Evaluation of Venous Thromboembolism (VTE) Prophylaxis in Medically Ill Patients March 2005 March 2007
NCT00814177 Completed Phase 2 Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients July 2006 April 2009
NCT00830570 Completed The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings July 2007 January 2010
NCT00831714 Completed Xarelto for VTE Prophylaxis After Hip or Knee Arthroplasty February 2009 April 2013
NCT00844415 Completed Phase 2 Safety and Tolerability of Dabigatran Etexilate in Adolescents June 2009
NCT00851864 Completed Phase 4 Safety and Efficacy of Therapeutic Anticoagulation With Tinzaparin During Pregnancy Via Weight-based Dosing October 2007 May 2011
NCT00853463 Completed N/A Discharge ALERT: Quality Improvement Initiative April 2009 May 2011
NCT00902928 Completed Phase 2/Phase 3 A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery April 2009 August 2010
NCT00913120 Completed Phase 2/Phase 3 Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Hip Replacement Surgery May 2009 March 2010
NCT00917254 Completed Phase 2/Phase 3 Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery May 2009 January 2010
NCT00937820 Completed Phase 3 Prevention of Recurrence of Venous Thromboembolism in Patients With a History of Venous Thromboembolism June 2009 December 2010
NCT00937911 Completed Phase 3 Prevention of Venous Thromboembolism in Subjects Undergoing Hip Fracture Surgery or Surgery in the Lower Extremities June 2009 April 2010
NCT00942435 Completed Phase 3 A Study to Assess the Effect of YM150 for Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery June 2009 April 2010
NCT00952380 Completed Phase 2 Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients August 2009 March 2018
NCT00954395 Completed DULCIS (D-dimer and ULtrasonography in Combination Italian Study) September 2008 June 2012
NCT00966277 Completed Phase 4 Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients April 2010 September 2014
NCT00973596 Completed The Swiss Venous Thromboembolism Cohort 65+ September 2009 December 2013
NCT00978445 Completed N/A Remote Home Prothrombin Time (PT)/International Normalized Ratio (INR) Monitoring and Patient Management System September 2009 August 2010
NCT00986154 Completed Phase 3 Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study). October 2009 April 2013
NCT01004939 Completed Retrospective Study of Patients Who Were Treated With Fondaparinux Pre-, Peri- and/or Postpartum for Prophylaxis or Treatment of Venous Thromboembolism March 2010 July 2010
NCT01014403 Completed Phase 1 Delayed Versus Early Enoxaparin Prophylaxis After Traumatic Brain Injury (TBI) November 2009 May 2011
NCT01028950 Completed Phase 3 YM150 for Prevention of Venous Thromboembolism in Patients With Acute Medical Illness May 2009 April 2010
NCT01029743 Completed Xarelto Regulatory Post-Marketing Surveillance December 2009 January 2016
NCT01046903 Completed An Observational Study On The Safety And Tolerability Of Prolonged Thrombosis Prophylaxis With Fragmin® March 2010 February 2011
NCT01050153 Completed N/A The Clinical Utility of Thrombelastography in Guiding Prophylaxis of Venous Thromboembolism Following Trauma March 2010 December 2011
NCT01083732 Completed Phase 2 Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age March 2010 February 2016
NCT01119261 Completed Phase 4 EUropean Pharmacogenetics of AntiCoagulant Therapy - Acenocoumarol November 2010 June 2013
NCT01119300 Completed Phase 4 EUropean Pharmacogenetics of AntiCoagulant Therapy - Warfarin January 2011 October 2013
NCT01130025 Completed Phase 3 Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer August 2010 May 2014
NCT01139658 Completed Prevention of Venous Thromboembolic Events After Elective Orthopaedic Surgery in Patients Treated With PRADAXA August 2010 September 2012
NCT01140386 Completed Prevalence and Risk Factors of Venous Thromboembolism in Hospitalized Pediatric Patients May 2009 March 2010
NCT01176305 Completed Venous Thromboembolism in Pregnant and Puerperal Women in Denmark 1995-2005
NCT01181102 Completed Phase 3 A Phase 3 Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty March 2009 February 2010
NCT01181141 Completed Phase 3 Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Hip Fracture Surgery October 2008 February 2010
NCT01181167 Completed Phase 3 A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty May 2009 March 2010
NCT00000614 Completed Phase 3 Prevention of Recurrent Venous Thromboembolism (PREVENT) September 1998 August 2004
NCT01203098 Completed Phase 2 A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty July 2008 June 2009
NCT01205932 Completed Phase 3 Dose-confirmatory Bridging Study in Total Hip Replacement September 2010 August 2011
NCT01206972 Completed Phase 3 Dose-confirmatory Bridging Study in Total Knee Replacement October 2010 June 2011
NCT01210755 Completed Phase 4 Study in Healthy Volunteers of the Reversion by Haemostatic Drugs of the Anticoagulant Effect of New Anti-thrombotics November 2010 June 2011
NCT01225822 Completed Phase 2 BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement Surgery November 2002
NCT01234064 Completed Phase 3 Graduated Compression Stockings (GCS) Pilot Substudy November 2010 December 2011
NCT01267305 Completed N/A The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery January 2011 August 2013
NCT01274637 Completed Phase 3 PROSPER: PostpaRtum PrOphylaxiS for PE Randomized Control Trial Pilot March 2011 January 2014
NCT01277536 Completed Explicit Assessment of Thromboembolic Risk and Prophylaxis for Medical Patients in Switzerland December 2010 November 2011
NCT01304108 Completed Phase 4 Improving Venous Thromboembolism Prophylaxis January 2009 May 2010
NCT01308528 Completed Phase 3 Prophylactic Use of Sodium Enoxaparin for Venous Thromboembolism in High-Risk Abdominal Surgery February 2015 April 2017
NCT01317160 Completed N/A Compression Treatment Effects on Complications and Healing of Achilles Tendon Rupture March 2011 September 2018
NCT01345773 Completed Incidence of Venous Thromboembolism Following Surgery in Patients With Gastric Cancer May 2010
NCT01348074 Completed Phase 2 Reinitiation of Anticoagulation After Temporary Withdrawal of Vitamin K Antagonist April 2011 December 2013
NCT05794165 Enrolling by invitation Phase 2 Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism September 5, 2023 March 2027
NCT03244020 Enrolling by invitation Phase 4 LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology February 16, 2018 July 1, 2028
NCT06393868 Not yet recruiting Phase 3 Reducing Gastrointestinal Bleeding With Proton Pump Inhibitor Therapy in Acute Venous Thromboembolism June 2024 September 2024
NCT06353373 Not yet recruiting Smart Technology Facilitated Venous Thromboembolism Prophylaxis Based on Bundled Evidence-based Prevention Strategies September 1, 2024 February 28, 2025
NCT02877251 Not yet recruiting Mexican Multidisciplinary Registry of Patients With Venous Thromboembolic Disease December 2023 December 2024
NCT06451003 Not yet recruiting N/A Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery June 1, 2024 December 31, 2026
NCT06452342 Not yet recruiting Phase 4 TRanEXamic Acid to Decrease Heavy Menstrual Bleeding in Individuals Anticoagulated for Venous Thromboembolism Pilot Study June 2024 April 2026
NCT06440694 Not yet recruiting Phase 3 Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial) June 3, 2024 December 1, 2027
NCT05683808 Not yet recruiting Phase 2 Venous Thromboembolism Prevention in Outpatients With Glioma January 16, 2023 December 31, 2024
NCT06372730 Not yet recruiting N/A Residual Pulmonary Vascular Obstruction Index Computed With Ventilation/Perfusion SPECT/CT Imaging to Predict the Risk of Venous Thromboembolism Recurrence in Patients With Pulmonary Embolism (PRONOSPECT) April 2024 January 2029
NCT06350331 Not yet recruiting N/A Smart Technology Facilitated Patient-centered Venous Thromboembolism Management May 1, 2024 October 31, 2024
NCT05881798 Not yet recruiting Post-Market Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set Study June 2024 January 2029
NCT06454630 Not yet recruiting Phase 2 A Trial to Learn How Well REGN7508 Works for Preventing Blood Clots After a Knee Replacement in Adult Participants July 10, 2024 March 26, 2025
NCT06382038 Not yet recruiting N/A Smart Technology Facilitated Patient-centered Care for Patients With Pulmonary Thromboembolism May 1, 2024 October 31, 2026
NCT06350344 Not yet recruiting N/A Smart Technology Facilitated Patient-centered Venous Thromboembolism Management November 1, 2024 October 31, 2027
NCT06418633 Not yet recruiting N/A Variations in the Hemostatic System Induced by a Standardized Walking Test May 15, 2024 May 1, 2026
NCT06189313 Not yet recruiting N/A CLEANer Aspiration for Pulmonary Embolism July 22, 2024 August 20, 2025
NCT06195540 Not yet recruiting Phase 3 RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing May 31, 2024 August 31, 2026
NCT05920343 Not yet recruiting Phase 2/Phase 3 VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy February 2024 February 2026
NCT06299111 Not yet recruiting Phase 2 A Trial to Learn How Well REGN9933 and REGN7508 Work for Preventing Blood Clots, and How Safe They Are, in Adults Who Have a Peripherally Inserted Central Catheter (PICC) August 31, 2024 June 8, 2026
NCT05900388 Not yet recruiting A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolism (VTE) December 31, 2024 June 30, 2029
NCT06284343 Not yet recruiting Development and Validation of a Risk Prediction Model for Venous Thromboembolism in Gynecological Cancer Patients Undergoing Systemic Antineoplastic Treatment: The Gynecological Cancer Associated Thrombosis (GynCAT) Study April 1, 2024 September 30, 2026
NCT06194617 Recruiting Rivaroxaban in Elderly Chinese Venous Thromboembolism Patients April 1, 2021 September 30, 2026
NCT05449327 Recruiting N/A Xarelto for Thromboprophylaxis After Total Hip and Total Knee Arthroplasty February 1, 2023 December 21, 2025
NCT05476913 Recruiting N/A GEKO Venous Thromboembolism Prevention Study July 6, 2023 June 30, 2025
NCT04319627 Recruiting Phase 3 Statins for Venous Event Reduction in Patients With Venous Thromboembolism February 10, 2021 January 2027
NCT06129760 Recruiting N/A Glioblastoma Remote Monitoring and Care - Research Protocol April 30, 2024 January 1, 2027
NCT03935451 Recruiting Early Phase 1 Postoperative Extended Venous Thromboprophylaxis in Inflammatory Bowel Disease September 1, 2021 February 1, 2026
NCT02943343 Recruiting The China Pulmonary Thromboembolism Registry Study January 1, 2009 December 31, 2025
NCT04022915 Recruiting Phase 1 PET Fibrin Imaging of DVT and PE May 13, 2019 December 31, 2024
NCT05536791 Recruiting A Study in Europe Based on Medical Records That Looks at the Safety of Dabigatran in Children Below 2 Years of Age Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot November 24, 2022 October 1, 2024
NCT04066764 Recruiting Phase 3 Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters May 8, 2020 October 1, 2024
NCT04075240 Recruiting Phase 3 VTE Prevention Following Total Hip and Knee Arthroplasty February 4, 2021 April 2026
NCT06166537 Recruiting N/A GRACE: Evaluating Compression Stockings in Patients That Require Extended Duration Pharmacological Thromboprophylaxis April 27, 2024 March 31, 2027
NCT05860790 Recruiting Prospective Validation of Clinical Prediction Model for Venous Thromboembolism Following Neurosurgery March 10, 2023 July 1, 2023
NCT02219984 Recruiting START-Register: Survey on Anticoagulated Patients Register October 2011 November 2027
NCT05628207 Recruiting Evaluation of the SCALED (SCaling AcceptabLE cDs) May 16, 2023 November 16, 2025
NCT06168331 Recruiting Chinese Community Inpatient Thromboembolism October 10, 2023 December 31, 2024
NCT04211181 Recruiting N/A CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism January 1, 2022 March 31, 2024
NCT05701917 Recruiting N/A DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis January 6, 2023 October 31, 2025
NCT04257487 Recruiting Phase 3 Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study) December 21, 2020 December 2, 2023
NCT04263038 Recruiting Phase 4 Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism May 15, 2020 May 2026
NCT05735639 Recruiting Phase 4 THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE) January 22, 2024 December 31, 2026
NCT04295486 Recruiting Phase 2 Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty March 1, 2021 March 1, 2025
NCT04600609 Recruiting Examining the Experiences of Children With Blood Disorders November 9, 2020 December 2025
NCT03041805 Recruiting Caprini Score in Venous Surgery: a Prospective Cohort Study January 1, 2017 January 1, 2025
NCT06257290 Recruiting The Role of Platelet TLRs in Platelet Activation During VTE October 11, 2023 June 2026
NCT05029063 Recruiting Phase 3 Primary Thromboprophylaxis in Patients With Malignancy and Central Venous Catheters October 5, 2022 December 2027
NCT05033314 Recruiting Phase 3 THromboprophylaxis In Sickle Cell Disease With Central Venous Catheters (THIS) June 7, 2022 December 1, 2024
NCT05058924 Recruiting N/A Low Molecular Weight hEparin vs. Aspirin Post-partum August 29, 2021 June 30, 2024
NCT04504318 Recruiting Phase 1/Phase 2 Apixaban vs Enoxaparin Following Microsurgical Breast Reconstruction-An RCT August 12, 2020 August 1, 2024
NCT06416280 Recruiting Inter-observer Reliability of the TRiP(Cast) Score in Patients With Trauma to a Lower Limb Requiring Immobilisation May 16, 2024 December 30, 2025
NCT04539301 Recruiting Multicentric Prospective Validation of a Universal Test to Quantify Apixaban, Rivaroxaban, Danaparoid and Fondaparinux Levels April 1, 2021 May 1, 2024
NCT06278051 Recruiting An Observational Study to Learn More About How Safe Treatment With Rivaroxaban is in Children in Japan With Venous Thromboembolism February 19, 2024 December 31, 2024
NCT01158482 Recruiting Filter Initial & Long Term Evaluation After Placement and Retrieval Registry June 2010 June 2030
NCT05171049 Recruiting Phase 3 A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE May 5, 2022 September 2025
NCT02832245 Recruiting Computerized Registry of Patients With Venous Thromboembolism (RIETE) March 2001 December 2027
NCT05171075 Recruiting Phase 3 A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE September 27, 2022 September 2025
NCT05939960 Recruiting Application of a New Type of Whole Blood Coagulation Time Measurement in Evaluating the Hypercoagulable State of Malignant Tumors July 1, 2023 September 30, 2024
NCT05964621 Recruiting Venous Thromboembolism in Primary Pancreatic Tumour Resection September 1, 2023 October 1, 2024
NCT05208216 Recruiting N/A Neuromuscular Stimulation Versus Intermittent Compression for Venous Thromboembolism Prophylaxis in Critical Care November 1, 2022 May 1, 2024
NCT03259204 Recruiting N/A Swedish Multicenter Trial of Outpatient Prevention of Leg Clots September 1, 2018 December 31, 2025
NCT03266783 Recruiting Phase 4 Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism December 13, 2017 December 2024
NCT05226793 Recruiting Medication Use Evaluation for Enoxaparin in Hospitalized COVID-19 Patients November 17, 2021 November 17, 2024
NCT05966740 Recruiting A Study in the United Sates That Looks at the Safety and Effectiveness of Pradaxa Pellets in Children Aged 3 Months to Less Than 12 Years Who Need Treatment of a Blood Clot or Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot October 31, 2023 June 28, 2029
NCT05229471 Recruiting Management of Recurrent Venous Thromboembolism During Anticoagulant Treatment in Cancer Patients - a Prospective Cohort Study June 2, 2020 December 31, 2024
NCT06020560 Recruiting Phase 4 Study of Low Molecular Weight Heparins March 23, 2023 March 23, 2025
NCT05240508 Recruiting Platelet FcGammaRIIa and Risk of Venous Thromboembolism in Cancer January 1, 2022 December 31, 2024
NCT06302478 Recruiting N/A 5E Program for Preventing Venous Thromboembolism in Patients With Spinal Cord Disorders March 12, 2024 October 31, 2024
NCT05306821 Recruiting N/A Effectiveness of Interventions for Hospital Medical Thromboprophylaxis: a Bicentric Swiss Quality-improvement Study September 1, 2020 December 31, 2024
NCT04766216 Recruiting N/A Warfarin Patient Self-management Implementation in the US Healthcare System March 15, 2023 April 30, 2025
NCT05347550 Recruiting N/A Examining the Benefit of Graduated Compression Stockings in the Prevention of vEnous Thromboembolism in Low-risk Surgical Patients September 8, 2022 December 31, 2025
NCT05351749 Recruiting N/A Implementing Prescriber-Pharmacist Collaborative Care for Evidence-based Anticoagulant Use August 1, 2022 January 2026
NCT05378035 Recruiting DOAC in Chinese Patients With Atrial Fibrillation September 28, 2022 December 31, 2027
NCT05756244 Recruiting PRospective Evaluation of Peripartum Anticoagulation ManaGement for ThrOmboembolism April 4, 2023 December 31, 2029
NCT05378308 Recruiting NOACs Use in AF or VTE (SUNSHINE Registry) June 6, 2022 May 31, 2027
NCT06073366 Recruiting Long-term Surveillance of Patients With Venous Thromboembolism: a Nationwide Prospective Cohort Study May 1, 2013 April 30, 2025
NCT05891886 Recruiting Early Phase 1 Supplemental Oxygen in Pulmonary Embolism (SO-PE) October 1, 2023 June 30, 2027
NCT05382481 Recruiting N/A Anti Xa Monitoring Low Molecular Weight Heparin on Prevention of Venous Thromboembolism May 16, 2022 December 31, 2024
NCT06087952 Recruiting N/A Leiden Thrombosis Recurrence Risk Prevention June 18, 2021 June 1, 2027
NCT03728166 Recruiting N/A Computerized Decision Support for Prevention of VTE in Hospitalized Medical Patients Across the Continuum of Care (DC-eALERT) February 1, 2019 December 31, 2024
NCT03781531 Recruiting Identification of Novel Biomarkers to Aid in the Detection of Occult Cancer in Patients With Venous Thromboembolism March 1, 2017 December 31, 2028
NCT04992195 Recruiting Impact of COVID-19 Vaccines on Cerebrovascular Health July 5, 2021 December 31, 2026
NCT04999176 Recruiting Phase 3 Venous Thromboembolism Prophylaxis After Gynecological Pelvic Cancer Surgery With Rivaroxaban vs Enoxaparin October 22, 2020 July 15, 2024
NCT03006562 Terminated Phase 4 PREvention of VENous ThromboEmbolism Following Radical Prostatectomy July 1, 2017 November 1, 2019
NCT00714597 Terminated Phase 3 Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients With Restricted Mobility July 2008 March 2009
NCT02066597 Terminated Phase 2 Single Session Percutaneous Mechanical Thrombectomy for the Treatment of Ilio-femoral Deep Vein Thrombosis: A Preliminary Evaluation November 2013
NCT00981903 Terminated Phase 2 Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With Cancer July 2005 October 2015
NCT01817257 Terminated Phase 2 Anticoagulation Length in Cancer Associated Thrombosis December 2013 February 2015
NCT01573169 Terminated Phase 3 PREvention of VENous Thromboembolism In Hemorrhagic Stroke Patients May 2012 March 2020
NCT00149357 Terminated Fetal Loss in Women With Unprovoked Thromboembolism (FLUTE) July 2005 December 2008
NCT00303407 Terminated Prophylaxis of Venous Thrombo-Embolism in Cancer Patients Under Palliative Care January 2001 July 2002
NCT02331095 Terminated Early Phase 1 Statin Use in Patients With Acute VTE January 2015 May 20, 2020
NCT03297359 Terminated Phase 2 WAVe Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous Thromboembolism March 21, 2018 November 30, 2023
NCT00437892 Terminated Phase 2 Statins to Reduce D-dimer Levels in Patients With Venous Thrombosis May 2007 May 2011
NCT01051297 Terminated Obstructive Sleep Apnea and Venous Thromboembolism March 2009 May 2015
NCT00428441 Terminated N/A D-dimer to Predict Recurrence in Patients With Multiple Episodes of Venous Thromboembolism May 2007 May 2011
NCT01088334 Terminated Mortality Due to Malignancy in Patients With Idiopathic Venous Thromboembolism December 2002 December 2008
NCT03090880 Terminated Phase 3 Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE) September 14, 2018 August 18, 2021
NCT00437697 Terminated Phase 4 Thromboprophylaxis in Critically Ill Patients April 2003 April 2005
NCT00876915 Terminated Phase 3 A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients July 2009 December 2014
NCT04748393 Terminated Risk, Predictors, Impact and Outcome of Anticoagulation-associated Abnormal Menstrual Bleeding September 1, 2018 February 1, 2021
NCT03678506 Terminated Phase 4 Apixaban for Extended Anticoagulation (APIDULCIS) August 16, 2018 January 31, 2023
NCT01153698 Terminated Pradaxa (Dabigatran Etexilate) VTE Prevention After Elective Total Hip or Knee Replacement Surgery August 2010 December 21, 2011
NCT01608919 Terminated N/A Predictive Value of Whole Blood Coagulation Parameters for Post-discharge Venous Thromboembolism After Cancer Resection November 2012 January 2014
NCT01164046 Terminated Phase 3 Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism August 2010 July 2014
NCT02901067 Terminated Phase 2 STAT-STatin and Aspirin in Trauma February 3, 2017 August 1, 2021
NCT02396732 Terminated Phase 4 Aspirin and Enoxaparin for VTE in Trauma February 2016 May 15, 2018
NCT03977363 Terminated The Portuguese Survey on Anticoagulated Patients Register (START-Portugal-Register) January 27, 2020 March 2, 2023
NCT03195010 Terminated Phase 2 Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia June 9, 2017 December 21, 2018
NCT01195727 Terminated Phase 1 Multiple-Dose Study Apixaban in Pediatric Subjects With an Indwelling Central Venous Catheter July 26, 2011 July 16, 2012
NCT03196349 Terminated Phase 4 Comparison of Oral Anticoagulants for Extended VEnous Thromboembolism August 1, 2018 May 1, 2019
NCT03200613 Terminated Phase 2 Apixaban For Thromboprophylaxis In Patients With Acute Spinal Cord Injury September 1, 2017 August 1, 2019
NCT02201277 Terminated N/A ODEN Trial: Option vs. Denali IVC Filters May 27, 2014 April 27, 2018
NCT00789399 Terminated N/A A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis November 19, 2009 September 21, 2013
NCT00445328 Terminated Phase 4 Dalteparin vs Unfractionated Heparin For The Prevention Of Venous Thromboembolism (VTE) In Hospitalized Acutely Ill Medical Patients June 2007 July 2008
NCT02945280 Terminated Phase 4 Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis February 22, 2017 November 11, 2021
NCT04106700 Terminated Phase 2 Prophylaxis With Apixaban in Transplant Eligible Patients With Multiple Myeloma Receiving Induction Therapy With IMiDs April 12, 2019 October 5, 2020
NCT02583191 Terminated Phase 3 Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer Patients March 23, 2016 August 19, 2019
NCT01847196 Terminated N/A Angel® Catheter Early Feasibility Clinical Study November 2013 June 2014
NCT00493896 Terminated Phase 3 Safety of Fondaparinux as Routine VTE Prophylaxis in Medical ICU Patients July 2007 April 2010
NCT02679664 Unknown status Phase 2 StAtins for Venous Event Reduction in Patients With Venous Thromboembolism Pilot Study November 2016 July 2020
NCT04663477 Unknown status Development and Validation of the Patient-completed Caprini Risk Score January 1, 2019 December 31, 2021
NCT04710732 Unknown status Phase 4 Individual Dose Adjustment of Low-molecular-weight-heparin by Thromodynamics Test. March 1, 2021 January 31, 2024
NCT02898051 Unknown status Anti Xa Activity in Cancer Patients Receiving Low-molecular-weight Heparin for Venous Thromboembolism August 2011 January 2018
NCT02911012 Unknown status Multiple Algorithms System Of All Scores in Embolism (MOSE) October 2016 October 2017
NCT00856076 Unknown status Venous Thromboembolism in Pregnancy Study January 2005 December 2023
NCT00925808 Unknown status Cancer Patients Diagnosed With Unsuspected Venous Thromboembolism (VTE) on Routine Computed Tomography (CT) Scans June 2009 June 2021
NCT00934167 Unknown status Phase 2/Phase 3 Efficacy of Sodium Heparin for Prophylaxis of Venous Thromboembolism in Surgical Patients May 2010 September 2011
NCT02978950 Unknown status N/A SToP: Venous Thromboembolism Screening in the Trauma Population March 20, 2017 June 2020
NCT03045406 Unknown status Phase 3 Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer April 13, 2017 December 1, 2019
NCT00501358 Unknown status Sleep Apnea and Tromboembolic Disease
NCT05066867 Unknown status LMWH Compliance in Pregnancy January 1, 2021 April 1, 2022
NCT00354796 Unknown status The Effect of Reduced Dose of Enoxaparin on the Outcomes of Treatment With Enoxaparin July 2006 October 2015
NCT03157843 Unknown status Rate of Venous Thrombosis in Acutely Ill Patients Hospitalized in Internal Medicine Wards February 2015 January 2018
NCT05189002 Unknown status Phase 2 A Study to Evaluate Dimolegin in Prevention of Thromboembolic Complications During Knee Replacement May 31, 2019 December 31, 2022
NCT03240120 Unknown status Phase 3 A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism September 1, 2017 December 31, 2021
NCT03277001 Unknown status N/A Study of Prophylactic Effect of Rivaroxaban on Venous Thromboembolism in AECOPD October 1, 2017 December 31, 2019
NCT01321788 Unknown status Venous Thromboembolism Prophylaxis Post Cesarean Section January 2011 January 2013
NCT01357941 Unknown status Need for Antepartum Thromboprophylaxis in Pregnant Women With One Prior Episode of Venous Thromboembolism (VTE) September 2011 September 2014
NCT03309293 Unknown status N/A Construction and External Validation of a Predictive Clinico-biological Score of the Risk of Venous Thrombosis in Women Under Combined Oral Contraceptives October 2017 February 2022
NCT01363193 Unknown status N/A Safety and Efficacy of Lean Body Weight-based IV Heparin Dosing in Obese/Morbidly Obese Patients July 2011 December 2014
NCT01372514 Unknown status Institutional Registry of Thromboembolic Disease August 2006 January 2020
NCT01448746 Unknown status Phase 3 Optimal Prophylactic Method of Venous Thromboembolism (VTE) October 2011 August 2017
NCT03405571 Unknown status Validation of the 4TS RAM in the Prevention of Venous Thromboembolism in Patients With Plasma Cell Dyscrasias. June 1, 2014 June 30, 2022
NCT01504087 Unknown status ICU Venous Thromboembolism Incidence Study in a Chinese Population May 2011
NCT03426982 Unknown status Phase 4 Comparision Between Activated Partial Thromboplastin Time Versus Anti-Xa Activity in Heparin Monitoring March 1, 2018 October 30, 2018
NCT03563924 Unknown status Allo - Cancer - Thrombosis June 2018 September 2019
NCT03580577 Unknown status Risk Factors and Outcomes of Acute Venous Thromboembolism in Cirrhotic September 1, 2018 September 1, 2019
NCT03581708 Unknown status Venous Thromboembolism in Advanced Lung Cancer July 2018 June 2022
NCT03691753 Unknown status N/A Safety and Efficacy Study of Fitaya Vena Cava Filter September 29, 2018 December 2020
NCT01916707 Unknown status Phase 4 Weight Based Enoxaparin in Trauma Patients July 2013 December 2017
NCT03988101 Unknown status Phase 4 Role of Statin in Venous Dysfunction in Patients With Venous Thromboembolism Event September 19, 2019 November 2022
NCT02017743 Unknown status Effectiveness And Safety of LMWH Treatment in Cancer Patients Diagnosed With Non-High Risk Venous Thromboembolism December 2012 August 2014
NCT02066454 Unknown status Phase 3 Evaluation of the Use of Apixaban in Prevnetion of Thromboembolic Disease in Patients With Myeloma Trated With iMiDs April 2014 July 2017
NCT04128254 Unknown status Phase 4 A Prospective Study in Chinese Patients With Lower Extremity Ankle Fracture of Oral Anticoagulants to Prevent Venous Thromboembolism (VTE) January 2020 June 2021
NCT04130048 Unknown status Thrombus Elastography in Venous Thrombo-Embolism. October 10, 2019 December 14, 2019
NCT04141254 Unknown status Phase 3 Impact of Early Debriefing and Enhanced Educative Components on Direct Oral Anticoagulant Adherence After Venous Thromboembolism. December 27, 2019 December 2021
NCT04169269 Unknown status Phase 4 Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs Rivaroxaban January 13, 2020 December 2021
NCT04179487 Unknown status The OPTICA Study - The Optimised Computed Tomography Pulmonary Angiography (CTPA) in Pregnancy, Quality and Safety Study May 29, 2018 April 2024
NCT04335162 Unknown status Cardiovascular Complications and COVID-19 (CovCardioVasc-Study) February 28, 2020 August 31, 2021
NCT02480790 Unknown status Venous Thromboembolic Complications in Ovarian Cancer November 2014 September 2019
NCT02486666 Unknown status Phase 3 Pilot Feasibility and Safety of Administering Weight Adjusted Fixed LMWH Dose March 2016 December 2022
NCT02503904 Unknown status Phase 2/Phase 3 Tumescent Antibiotic Delivery for Prevention of Surgical Site Infection October 2015 December 2019
NCT00222677 Unknown status Phase 2/Phase 3 Aspirin for the Prevention of Recurrent Venous Thromboembolism May 2004
NCT00192829 Unknown status Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma June 2005
NCT01446510 Withdrawn Systematic Review and Meta-Analysis of Venous Thromboembolism (VTE) Risk Assessment in Hospitalized Medical Patients September 2011 April 2013
NCT05104229 Withdrawn Phase 3 SAVES-IBD: Safety & Efficacy of Aspirin vs. Standard of Care for VTE Prophylaxis After IBD Surgery June 1, 2024 January 1, 2026
NCT02900404 Withdrawn Verification of XAPPORT: a Decision Support App for Physicians Used for Patients Anticoagulated With Rivaroxaban in Terms of Anticoagulation Management in Elective Surgery: Verification Process of Medical Decision Algorithm February 15, 2017 March 31, 2017
NCT02735759 Withdrawn N/A Detecting Circulating Emboli in Patients With Acute Venous Thromboembolism July 2018 December 2019
NCT02707263 Withdrawn N/A Effect of Intravenous Continuous Infusion Heparin on Rates of Venous Thromboembolism in High-Risk, Critically Ill Patients March 2016 April 2017
NCT05887518 Withdrawn N/A The Effect of Sock Developed With Wearable Technology for TUR Surgery Patients on Hypothermia and Venous Thromboembolism December 1, 2023 October 1, 2024
NCT00541320 Withdrawn Phase 2 Phase IIa Venous Thromboembolism (VTE) Prevention Study In Total Knee Replacement (TKR) February 2007
NCT03988231 Withdrawn Phase 4 Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study July 2021 June 2023
NCT01890044 Withdrawn Multicenter Registry for Comparative Effectiveness Analysis of Venous Thromboembolism in Trauma Patients August 2013 October 2016
NCT00912483 Withdrawn Phase 3 Efficacy of Sodium Heparin in Prophylaxis of Venous Thromboembolism in Surgical Patients May 2010 January 2011
NCT01773174 Withdrawn Phase 2 Pharmacokinetics, Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 2 Years of Age January 2013 December 2015
NCT02420626 Withdrawn Evaluation of the Short and Long Term Performance and Clinical Outcomes of the Crux Vena Cava Filter System January 2016 May 2019
NCT01602432 Withdrawn Implementing a Tool to Identify Risk for Venous Thromboembolism in Cancer Patients November 2012 August 2013
MedGen concept unique identifier (MedGen Concept name)
C1861172
MedGen unique identifier (MedGen Concept name)
348285
MeSH unique ID (MeSH (Medical Subject Headings))
D054556